| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |